New launch! | Five high performance IVT Kits, covering the full spectrum of functionalized mRNA synthesis | Code baseScribe30 for 30% off

New launch! | Five high performance IVT Kits, covering the full spectrum of functionalized mRNA synthesis | Code baseScribe30 for 30% off

Integrated Oligo Synthesis and Conjugation Service

Integrated Oligo Synthesis and Conjugation Service

We are pleased to introduce a new partnership between baseclick GmbH and metabion AG.
This collaboration provides researchers, diagnostic developers, and pharmaceutical teams with a fully integrated workflow.

By combining metabion’s excellence in custom oligo synthesis with baseclick’s proprietary click chemistry platform, this partnership creates a seamless, efficient path from concept to functional oligos.

Why this collaboration matters

As demand grows for precisely functionalized oligonucleotides, researchers need workflows that reliably connect high‑quality synthesis with advanced chemical modification.
Our partnership solves this challenge through a coordinated, scalable approach.

  • One seamless workflow

    A coordinated process that integrates DNA/RNA/LNA/siRNA synthesis (metabion) with bioorthogonal conjugation and glyco‑targeting technologies (baseclick).
    No additional shipping steps, no compatibility issues—just one streamlined workflow.

  • Higher project reliability

    With aligned QC, harmonized documentation, and coordinated processing, your projects benefit from consistent quality and reduced operational complexity.

  • Expanded modification options

    Access a wide range of functional groups such as click‑handles, dyes, biotin, and advanced ligands including our Glyco Targeting Platform for receptor‑specific delivery.

  • Shorter development timelines

    With one point of contact and an integrated workflow, communication becomes faster and more efficient—helping you reach critical milestones sooner.

  • Direct expert support

    Both teams provide coordinated scientific guidance to help you select the right synthesis strategy, conjugation chemistry, and targeting approach for your application.

What this means for our customers
Together, we can support a broad range of applications from basic research and diagnostics to targeted oligonucleotide therapeutics by providing:

  • High‑purity oligos tailored to your design
  • Modular post‑synthetic conjugation options
  • Sugar‑ligand and receptor‑targeting strategies
  • Consistent project delivery from start to finish

Our joint offering ensures that you receive application‑ready, precisely functionalized oligos with the quality, flexibility, and reliability needed for today’s complex projects.

Learn more